Nationales Centrum fur Tumorerkrankungen   Report issue

Academic/Hospital Phase 2
Founded: Heidelberg Germany (2004)

Organization Overview

First Clinical Trial
2009
NCT01126866
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

NCT / DKFZ Heidelberg | NCT Heidelberg | NCT Heidelberg, Dep. of Medical Oncology | NCT-Med. Onkologie

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Carcinoma (Phase 2)

Chordoma (Phase 2)

Colorectal Neoplasms (Phase 2)

DNA Repair-Deficiency Disorders (Phase 2)

Esophageal Neoplasms (Phase 2)

Melanoma (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Stomach Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 12